Genoplex Announces Partnership with NVIDIA to Redefine Care with AI that Connects Patients to Advanced Therapies

Boulder, CO – December 11, 2024 – Genoplex, a leading health technology company dedicated to connecting healthcare providers and patients to life-saving advanced therapies through its AI-powered Advanced Therapy Connect™ platform,today announced that it is joing the NVIDIA Inception program for start-ups. This collaboration will leverage NVIDIA’s AI infrastructure and expertise to enhance thecapabilities of Genoplex’s digital agent, accelerating patient referrals and reducingtime from diagnosis to treatment.

Genoplex’s Advanced Therapy Connect platform streamlines patient access to therapies such as cell and gene therapies, and radiopharmaceuticals while also reducing complexity and administrative burden of care coordination for healthcareprofessionals at qualified treatment centers.

By integrating NVIDIA’s cutting-edge AI microservices, including the NVIDIA CUDA-X platform and the NeMo framework, Genoplex will expand its ability to process vast datasets, support scalable AI model deployment, and develop innovative domain-specific AI solutions. These enhancements will enable delivery of end-to-end real-time patient journey data, clinical workflow integration, and predictive analytics specific to advanced therapies, including cell therapies, gene therapies and radiopharmaceuticals.

Key initiatives under this partnership include:

High-Performance AI Models for Patient Referral and Workflow Optimization: NVIDIA’s microservices will enable Genoplex’s digital agent to improve patient identification and shorten the time from referral to patient intake while streamlining healthcare provider workflows with low-latency AI model deployment.

Large-Scale Multi-Modal Data Processing: Leveraging NVIDIA’s CUDA-Xplatform, Genoplex will accelerate the processing of clinical, genomic, and operational data to refine its proprietary AI algorithms. This will support precise and timely connections between patients and healthcare providers.

Development of Advanced Medical Large Language Models (LLMs): By integrating NVIDIA’s NeMo framework, Genoplex will enhance its conversational AI capabilities to support healthcare providers with real-time,actionable insights for treatment pathways, clinical decision-making, and patient engagement.

"AI is transforming how healthcare providers connect patients with advanced therapies. Through this collaboration, NVIDIA’s platform technologies will enable Genoplex to accelerate AI model development and scale its transformative solutions to democratize patient care.”  said Christopher Leidli, CEO of Genoplex.
‍
“With NVIDIA’s unparalleled AI expertise, we are poised to set a new standard for how patients access these life-saving treatments. Together, we are empowering healthcare providers with AI-driven tools to ensure no patient is left behind.”

About Genoplex:

Genoplex is a leading health technology company dedicated to democratizing patient access to advanced therapies. Powered by the Advanced Therapy Connect™ platform, Genoplex leverages AI to connect patients to life-saving treatments and streamline healthcare provider workflows. Headquartered in Boulder, CO, Genoplex partners with leading hospital treatment centers and pharmaceutical manufacturers to transform the advanced therapy patient access landscape.

New News Section on Our Website

We are excited to announce the launch of a news section on our website! This space will serve as a hub for all updates related to Genoplex and our platform, AdvancedTherapiesConnect.com. Stay tuned for the latest news, insights, and innovations in the field of advanced therapies.